Detecting colorectal cancer by 1H magnetic resonance spectroscopy of fecal extracts

Colorectal cancer is one of the most common cancers in the western world. Its early detection has been found to improve the prognosis of the patient, providing a wide window of opportunity for successful therapeutic interventions. However, current diagnostic techniques all have some limitations; there is a need to develop a better technique for routine screening purposes. We present a new methodology based on magnetic resonance spectroscopy of fecal extracts for the non‐invasive detection of colorectal cancer. Five hundred twenty‐three human subjects (412 with no colonic neoplasia and 111 with colorectal cancer, who were scheduled for colonoscopy or surgery) were recruited to donate a single sample of stool. One‐dimensional 1H magnetic resonance spectroscopy (MRS) experiments were performed on the supernatant of aqueous dispersions of the stool samples. Using a statistical classification strategy, several multivariate classifiers were developed. Applying the preprocessing, feature selection and classifier development stages of the Statistical Classification Strategy led to ∼87% average balanced sensitivity and specificity for both training and monitoring sets, improving to ∼92% when only crisp results, i.e. class assignment probabilities ≥75%, are considered. These results indicate that 1H magnetic resonance spectroscopy of human fecal extracts, combined with appropriate data analysis methodology, has the potential to detect colorectal neoplasia accurately and reliably, and could be a useful addition to the current screening tools. Copyright © 2009 John Wiley & Sons, Ltd.

[1]  B. Vogelstein,et al.  Prevalence of ras gene mutations in human colorectal cancers , 1987, Nature.

[2]  R L Somorjai,et al.  Nonlinear methods for discrimination and their application to classification of protein structures. , 1988, Journal of theoretical biology.

[3]  D. Eddy,et al.  Screening for colorectal cancer , 1992, The Lancet.

[4]  P. Nair,et al.  Human stools as a source of viable colonic epithelial cells , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  W. Mackinnon,et al.  Cell-surface fucosylation and magnetic resonance spectroscopy characterization of human malignant colorectal cells. , 1992, Biochemistry.

[6]  A. Okada,et al.  Increased aspartate and glutamate levels in both gastric and colon cancer tissues. , 1993, The Tokushima journal of experimental medicine.

[7]  Peter Russell,et al.  Computerized Consensus Diagnosis: A Classification Strategy for the Robust Analysis of MR Spectra. I. Application to 1H Spectra of Thyroid Neoplasms , 1995, Magnetic resonance in medicine.

[8]  D Fewer,et al.  Classification of 1H MR spectra of human brain neoplasms: The influence of preprocessing and computerized consensus diagnosis on classification accuracy , 1996, Journal of magnetic resonance imaging : JMRI.

[9]  R. Somorjai,et al.  Diagnostic potential for cancer via 1H magnetic resonance spectroscopy of colon tissue. , 1996, Anticancer research.

[10]  R. Somorjai,et al.  Classification of 1H MR spectra of biopsies from untreated and recurrent ovarian cancer using linear discriminant analysis , 1997, Magnetic resonance in medicine.

[11]  D. Rex,et al.  Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. , 1997, Gastroenterology.

[12]  R L Somorjai,et al.  The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra. , 1997, Cancer research.

[13]  D. Ransohoff,et al.  CLINICAL GUIDELINE: PART II: Screening for Colorectal Cancer with the Fecal Occult Blood Test: A Background Paper , 1997, Annals of Internal Medicine.

[14]  R L Somorjai,et al.  Near‐optimal region selection for feature space reduction: novel preprocessing methods for classifying MR spectra , 1998, NMR in biomedicine.

[15]  T. Church,et al.  Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. , 1999, Journal of the National Cancer Institute.

[16]  S. Thibodeau,et al.  Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. , 2000, Gastroenterology.

[17]  C E Mountford,et al.  Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine‐needle aspirates analysed using a statistical classification strategy , 2001, The British journal of surgery.

[18]  R L Somorjai,et al.  Magnetic resonance spectroscopy of the malignant prostate gland after radiotherapy: a histopathologic study of diagnostic validity. , 2001, International journal of radiation oncology, biology, physics.

[19]  R. Somorjai,et al.  The use of 1H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease , 2001 .

[20]  S. Goodman,et al.  Detecting colorectal cancer in stool with the use of multiple genetic targets. , 2001, Journal of the National Cancer Institute.

[21]  R. Somorjai,et al.  An ex vivo study exploring the diagnostic potential of 1H magnetic resonance spectroscopy in squamous cell carcinoma of the head and neck region , 2002, Head & neck.

[22]  Ray L. Somorjai,et al.  Accurate diagnosis and prognosis of human cancers by proton MRS and a three-stage classification strategy , 2002 .

[23]  P. Pickhardt,et al.  Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. , 2003, The New England journal of medicine.

[24]  Uwe Himmelreich,et al.  Pathology of Barrett's esophagus by proton magnetic resonance spectroscopy and a statistical classification strategy. , 2003, American journal of surgery.

[25]  I. Smith,et al.  Medical Diagnosis by High Resolution NMR of Human Specimens , 2003, IUBMB life.

[26]  B. Levin,et al.  Emerging Technologies in Screening for Colorectal Cancer: CT Colonography, Immunochemical Fecal Occult Blood Tests, and Stool Screening Using Molecular Markers , 2003, CA: a cancer journal for clinicians.

[27]  D. Ransohoff,et al.  Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. , 2004, The New England journal of medicine.

[28]  M. Widschwendter,et al.  Methylation changes in faecal DNA: a marker for colorectal cancer screening? , 2004, The Lancet.

[29]  J. Burdick,et al.  Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. , 2004, JAMA.

[30]  D. Ahlquist,et al.  Stool screening for colorectal cancer: molecular approaches. , 2005, Gastroenterology.

[31]  C. Mountford,et al.  Proton spectroscopy provides accurate pathology on biopsy and in vivo , 2006, Journal of magnetic resonance imaging : JMRI.

[32]  N. Serkova,et al.  Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics , 2006, Expert review of molecular diagnostics.

[33]  I. Wilson,et al.  Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. , 2007, Journal of proteome research.

[34]  Kirill Veselkov,et al.  Species variation in the fecal metabolome gives insight into differential gastrointestinal function. , 2008, Journal of proteome research.